The biotechnology company, Genocea Biosciences Inc. (GNCA) has tried to develop a working drug for many years. Its efforts included drug development for herpes, pneumonia,
On April 28, Genocea Bioseiences Inc. (GNCA) said that it has commenced restructuring and is exploring strategic alternatives to increase shareholder value. The announcement had
With the American Association for Cancer Research (AACR) Annual Meeting started on April 8, many immunology companies focused on oncological treatments are taking part in
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.